Granite Investment Partners LLC Decreases Holdings in Stryker Corporation $SYK

Posted by on Jul 9th, 2026

Granite Investment Partners LLC decreased its position in Stryker Corporation (NYSE:SYK – Free Report) by 15.5% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 47,288 shares of the medical technology company’s stock after selling 8,704 shares during the quarter. Stryker comprises 1.0% of Granite Investment Partners LLC’s holdings, making the stock its 23rd largest position. Granite Investment Partners LLC’s holdings in Stryker were worth $15,538,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Sankala Group LLC purchased a new position in shares of Stryker during the fourth quarter worth approximately $26,000. Godfrey Financial Associates Inc. purchased a new stake in shares of Stryker in the 4th quarter valued at $26,000. United Financial Planning Group LLC purchased a new stake in shares of Stryker in the 3rd quarter valued at $27,000. Atlas Capital Advisors Inc. bought a new position in shares of Stryker during the 4th quarter valued at $27,000. Finally, DJE Kapital AG purchased a new position in Stryker in the 4th quarter worth $28,000. 77.09% of the stock is currently owned by institutional investors.

Stryker Price Performance

Shares of Stryker stock opened at $327.17 on Thursday. The firm has a market cap of $125.42 billion, a PE ratio of 37.87, a price-to-earnings-growth ratio of 2.11 and a beta of 0.77. Stryker Corporation has a 12-month low of $281.00 and a 12-month high of $404.87. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62. The company’s fifty day simple moving average is $309.71 and its two-hundred day simple moving average is $338.22.

Stryker (NYSE:SYK – Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 EPS for the quarter, missing the consensus estimate of $2.98 by ($0.38). The firm had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $6.34 billion. Stryker had a net margin of 13.20% and a return on equity of 23.42%. The business’s revenue was up 2.6% on a year-over-year basis. During the same period last year, the company posted $2.84 earnings per share. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. As a group, equities analysts expect that Stryker Corporation will post 14.98 EPS for the current year.

Stryker Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be issued a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Tuesday, June 30th. Stryker’s dividend payout ratio is currently 40.74%.

Analysts Set New Price Targets

Several analysts have weighed in on SYK shares. JPMorgan Chase & Co. lowered their price target on shares of Stryker from $445.00 to $400.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Evercore set a $350.00 price objective on Stryker in a research note on Monday. Deutsche Bank Aktiengesellschaft set a $315.00 price objective on Stryker in a report on Friday, May 1st. Leerink Partners dropped their target price on Stryker from $410.00 to $407.00 and set an “outperform” rating for the company in a report on Friday, June 5th. Finally, Sanford C. Bernstein set a $410.00 price target on Stryker in a research report on Friday, May 1st. Seventeen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Stryker currently has an average rating of “Moderate Buy” and an average target price of $393.91.

View Our Latest Analysis on Stryker

Insider Buying and Selling

In related news, VP M Kathryn Fink sold 3,500 shares of Stryker stock in a transaction on Monday, May 11th. The shares were sold at an average price of $283.45, for a total value of $992,075.00. Following the sale, the vice president owned 177 shares in the company, valued at $50,170.65. The trade was a 95.19% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, VP Robert S. Fletcher sold 4,544 shares of Stryker stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $306.87, for a total transaction of $1,394,417.28. Following the sale, the vice president directly owned 10,582 shares in the company, valued at $3,247,298.34. The trade was a 30.04% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 323,264 shares of company stock valued at $100,659,489 over the last quarter. 4.60% of the stock is owned by company insiders.

Stryker Profile

(Free Report)

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

Featured Stories

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK – Free Report).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.